CD4 and AIDS: Of clients with documented baseline CD4 count (n = 292, 97.3%) or WHO clinical stage (n = 279, 93.0%), the median (Q1–Q3) CD4 count at enrollment was 280 (165–420); 16.1% were classified with AIDS (WHO stage III or IV); and 66.0% were ART eligible (WHO stage III/IV or CD4 ≤ 350 cells/μl).